Dapagliflozin and Blood Pressure in Patients with Chronic Kidney Disease and Albuminuria

Author:

Heerspink Hiddo JL,Provenzano Michele,Vart Priya,Jongs Niels,Correa-Rotter Ricardo,Rossing Peter,Mark Patrick B.,Pecoits-Filho Roberto,McMurray John JV,Langkilde Anna Maria,Wheeler David C.,Toto Robert B.,Chertow Glenn M.ORCID

Funder

AstraZeneca PLC

Publisher

Elsevier BV

Reference39 articles.

1. Renal Data System. USRDS 2021 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2021. https://adr.usrds.org/2021/chronic-kidney-disease/2-identification-and-care-of-patients-with-ckd. Accessed February 14, 2022.

2. Considerable international variation exists in blood pressure control and antihypertensive prescription patterns in chronic kidney disease;Alencar de Pinho;Kidney Int,2019

3. Chronic kidney disease and cardiovascular risk in six regions of the world (ISN-KDDC): a cross-sectional study;Ene-Iordache;Lancet Glob Health,2016

4. Effects of intensive BP control in CKD;Cheung;J Am Soc Nephrol,2017

5. 2021 clinical practice guideline for the management of blood pressure in chronic kidney disease;Kidney Int,2021

Cited by 2 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3